Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -238.32% is 35% below its 5-year average of -176.22%, near the high end of its 5-year range (-706.63%–-64.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.56% above its 12-month average of -263.53%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -238.32%.
RETURN ON INVESTED CAPITAL (ROIC)
-238.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-263.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-239.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-176.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-192.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-157.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.56%
CURRENT VS 3Y AVG
+0.43%
CURRENT VS 5Y AVG
-35.24%
CURRENT VS 10Y AVG
-23.56%
CURRENT VS 15Y AVG
-51.40%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 828 covered companies
CURRENT VS SECTOR MEDIAN
-568.60%
vs the sector median at left
Nuwellis, Inc.
Market Cap
$2.61M
Return on Invested Capital (ROIC)
-238.32%
TTM Avg
-263.53%
3Y Avg
-239.35%
5Y Avg
-176.22%
Market Cap
$2.54M
Return on Invested Capital (ROIC)
-237.93%
TTM Avg
-187.67%
3Y Avg
-136.08%
5Y Avg
-136.08%
Market Cap
$2.52M
Return on Invested Capital (ROIC)
-286.46%
TTM Avg
-159.21%
3Y Avg
-198.72%
5Y Avg
-198.72%
Market Cap
$2.77M
Return on Invested Capital (ROIC)
-476.39%
TTM Avg
-313.80%
3Y Avg
-198.00%
5Y Avg
-161.97%
Market Cap
$2.47M
Return on Invested Capital (ROIC)
-110.81%
TTM Avg
-123.52%
3Y Avg
-108.42%
5Y Avg
-102.13%
Market Cap
$2.84M
Return on Invested Capital (ROIC)
-4.46%
TTM Avg
-9.72%
3Y Avg
-10.30%
5Y Avg
1.55%
Market Cap
$2.39M
Return on Invested Capital (ROIC)
-58.05%
TTM Avg
-445.82%
3Y Avg
-256.67%
5Y Avg
-256.67%
Market Cap
$2.35M
Return on Invested Capital (ROIC)
-242.25%
TTM Avg
-196.63%
3Y Avg
-136.47%
5Y Avg
-108.21%
Market Cap
$2.37M
Return on Invested Capital (ROIC)
-59.84%
TTM Avg
-167.05%
3Y Avg
-109.85%
5Y Avg
-118.30%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nuwellis, Inc. (NUWE) | $2.61M | -238.32% | -263.53% | -239.35% | -176.22% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | -237.93% | -187.67% | -136.08% | -136.08% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | -286.46% | -159.21% | -198.72% | -198.72% |
| iSpecimen Inc. (ISPC)vs › | $2.77M | -476.39% | -313.80% | -198.00% | -161.97% |
| Jaguar Health, Inc. (JAGX)vs › | $2.47M | -110.81% | -123.52% | -108.42% | -102.13% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.84M | -4.46% | -9.72% | -10.30% | 1.55% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.39M | -58.05% | -445.82% | -256.67% | -256.67% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.35M | -242.25% | -196.63% | -136.47% | -108.21% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -59.84% | -167.05% | -109.85% | -118.30% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.31M | -71.90% | -86.03% | -72.74% | -64.31% |
ROIC
-238.3%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -238.32% |
| 2026-03-31 | -335.34% |
| 2025-12-31 | -331.82% |
| 2025-09-30 | -234.26% |
| 2025-06-30 | -177.88% |
| 2025-03-31 | -218.44% |
| 2024-12-31 | -150.42% |
| 2024-09-30 | -302.81% |
| 2024-06-30 | -636.26% |
| 2024-03-31 | -706.63% |
| 2023-12-31 | -258.73% |
| 2023-09-30 | -220.04% |
| 2023-06-30 | -164.79% |
| 2023-03-31 | -127.49% |
| 2022-12-31 | -84.97% |
| 2022-09-30 | -114.45% |
| 2022-06-30 | -98.71% |
| 2022-03-31 | -82.43% |
| 2021-12-31 | -72.03% |
| 2021-09-30 | -64.29% |
| 2021-06-30 | -71.00% |
| 2021-03-31 | -58.15% |
| 2020-12-31 | -103.66% |
| 2020-09-30 | -82.96% |
| 2020-06-30 | -177.81% |
| 2020-03-31 | -226.73% |
| 2019-12-31 | -804.35% |
| 2019-09-30 | -385.47% |
| 2019-06-30 | -200.84% |
| 2019-03-31 | -134.61% |
| 2018-12-31 | -286.99% |
| 2018-09-30 | -203.75% |
| 2018-06-30 | -207.48% |
| 2018-03-31 | -134.73% |
| 2017-12-31 | -90.52% |
| 2017-09-30 | -150.89% |
| 2017-06-30 | -123.76% |
| 2017-03-31 | -333.37% |
| 2016-12-31 | -371.93% |
| 2016-09-30 | -495.76% |
| 2016-06-30 | -211.81% |
| 2016-03-31 | -158.79% |
| 2015-12-31 | -127.81% |
| 2015-09-30 | -100.30% |
| 2015-06-30 | -81.00% |
| 2015-03-31 | -73.74% |
| 2014-12-31 | -88.27% |
| 2014-09-30 | -74.51% |
| 2014-06-30 | -64.63% |
| 2014-03-31 | -53.74% |
| 2013-12-31 | -44.21% |
| 2013-09-30 | -34.54% |
| 2013-06-30 | -83.90% |
| 2013-03-31 | -153.14% |
| 2012-12-31 | -114.83% |
| 2012-09-30 | -98.56% |
| 2012-06-30 | -2653.02% |
